BIOMARIN PHARMACEUTICAL INC

BMRN · Nasdaq · SIC 2834: Pharmaceutical Preparations
155
SEC Filings

Business Summary

Part I Overview BioMarin Pharmaceutical Inc. (BioMarin, we, us or our) is a leading, global rare disease biotechnology company focused on delivering medicines for people living with genetically defined conditions. Our San Rafael, California-based company, founded in 1997, has a proven track record of innovation, with eight commercial therapies and a strong clinical and preclinical pipeline. Using a distinctive approach to drug discovery and development, we seek to unleash the full potential of g...

Next Earnings

Q2 FY2026 — expected 2026-08-15

Key Facts from Earnings Calls

TypeSubjectDetailQuarter
topic_mentionBMRNdiscussed_in_filing Cybersecurity
topic_mentionBMRNdiscussed_in_filing Trusted Computing
topic_mentionBMRNdiscussed_in_filing Blockchain & Crypto
topic_mentionBMRNdiscussed_in_filing Supply Chain
topic_mentionBMRNdiscussed_in_filing Regulation
topic_mentionBMRNdiscussed_in_filing Healthcare & Bio
topic_mentionBMRNdiscussed_in_filing Sovereign & Government
topic_mentionBMRNdiscussed_in_filing Cybersecurity
topic_mentionBMRNdiscussed_in_filing Trusted Computing
topic_mentionBMRNdiscussed_in_filing Blockchain & Crypto
topic_mentionBMRNdiscussed_in_filing Supply Chain
topic_mentionBMRNdiscussed_in_filing Regulation
topic_mentionBMRNdiscussed_in_filing Healthcare & Bio
topic_mentionBMRNdiscussed_in_filing Sovereign & Government
topic_mentionBMRNdiscussed_in_filing Cybersecurity
topic_mentionBMRNdiscussed_in_filing Trusted Computing
topic_mentionBMRNdiscussed_in_filing Blockchain & Crypto
topic_mentionBMRNdiscussed_in_filing Supply Chain
topic_mentionBMRNdiscussed_in_filing Regulation
topic_mentionBMRNdiscussed_in_filing Healthcare & Bio

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-02-262025-12-310001048477-26-000004EDGAR86K words
2025-02-242024-12-310001048477-25-000007EDGAR
2024-02-262023-12-310001048477-24-000016EDGAR
2023-02-272022-12-310001048477-23-000009EDGAR
2022-02-252021-12-310001048477-22-000012EDGAR
2021-02-262020-12-310001048477-21-000008EDGAR
2020-02-272019-12-310001048477-20-000009EDGAR
2019-02-282018-12-310001564590-19-005033EDGAR
2018-02-262017-12-310001564590-18-003114EDGAR
2017-02-272016-12-310001564590-17-002483EDGAR

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-10-282025-09-300001048477-25-000107EDGAR45K words
2025-08-052025-06-300001048477-25-000090EDGAR
2025-05-022025-03-310001048477-25-000051EDGAR
2024-10-312024-09-300001048477-24-000152EDGAR
2024-08-052024-06-300001048477-24-000126EDGAR
2024-04-262024-03-310001048477-24-000070EDGAR
2023-11-022023-09-300001048477-23-000044EDGAR
2023-08-022023-06-300001048477-23-000029EDGAR
2023-04-282023-03-310001048477-23-000020EDGAR
2022-10-282022-09-300001048477-22-000033EDGAR
2022-08-042022-06-300001048477-22-000027EDGAR
2022-04-292022-03-310001048477-22-000018EDGAR

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-03-160001193125-26-107314EDGAR1K words
2026-02-230001048477-26-000002EDGAR
2026-02-120001193125-26-048736EDGAR
2026-01-290001193125-26-029401EDGAR
2026-01-260001193125-26-021718EDGAR
2026-01-120001193125-26-010508EDGAR
2025-12-220001193125-25-327828EDGAR
2025-12-190001193125-25-325856EDGAR
2025-12-170001193125-25-322704EDGAR
2025-10-270001048477-25-000104EDGAR

155 total filings indexed. 123 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA ADIL — ADIAL PHARMACEUTICALS, INC.

Company Identity

CIK0001048477
TickerBMRN
ExchangeNasdaq
SIC2834: Pharmaceutical Preparations
IncorporatedDE

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: 18161efbfef168986adf70422486a4d49ea4f341d5e2ecd0f10a346f9f2f0cd5
parent: 58ea6fa6d1a072e37fe7a2fd112bf1981c26adbb7635452e9112ecd84f1d8e9f
content hash: f865bf2ef91bb622b8a46ddd9d86383b698909353046650683f05da1e8c1790f
signed: 2026-04-13T04:44:02.325Z
sources: 22 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf